Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Acta Cytologica|June 7, 2003
Nuclear grooves in normal and abnormal cervical smearsFariba Payandeh, Leopold G KossUrology|January 16, 2008
Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experienceWinston E Barzell, Myron R MelamedThe Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 6, 2017
Rapid Analysis of Normal and Abnormal Cell Types in Human Semen and Testis Biopsies by Flow Cytometry 12Donald P Evenson, Myron R MelamedActa Cytologica|March 29, 2002
Plasmacytoid urothelial carcinoma of the bladder. A case report and the first description of urinary cytologyXin-min Zhang, Abdelmonem Elhosseiny, Myron R MelamedActa Cytologica|August 19, 2003
Simultaneous cytomegalovirus infection and Kaposi's sarcoma of the thyroid diagnosed by fine needle aspiration in an AIDS patient. A case report and first cytologic description of the two entities occurring togetherXinmin Zhang, Dina el-Sahrigy, Abdelmonem Elhosseiny, et al.Medical Hypotheses|January 30, 2007
Mechanisms of progression of ductal carcinoma in situ of the breast to invasive cancer. A hypothesisRubina Cocker, Maja H Oktay, Jaya L Sunkara, et al.Acta Cytologica|February 19, 2004
Signet-ring follicular adenoma of the thyroid diagnosed by fine needle aspiration. Report of a case with cytologic descriptionDina el-Sahrigy, Xin-min Zhang, Abdelmonem Elhosseiny, et al.Human Pathology|April 4, 2003
Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomasMaja H Oktay, Kutluk Oktay, Diane Hamele-Bena, et al.Human Pathology|September 20, 2011
Predictors of disease progression in ductal carcinoma in situ of the breast and vascular patternsEsther H Adler, Jaya L Sunkara, Arthur S Patchefsky, et al.The Journal of Urology|July 24, 2012
Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancerWinston E Barzell, Myron R Melamed, Paul Cathcart, et al.Pageof 2